operates a Bay Area wet lab where Claude directs physical biology experiments to test biological theories, focused on fundamental biology rather than drug discovery
Home › AI Use-Case Library › AI in R&D & discovery: 22 real deployments
AI in R&D & discovery: 22 real deployments
Named deployments in R&D & discovery, grouped by industry.
Software & Tech 8 deployments
Running 30,000 concurrent Claude agents internally, with Claude leading or collaborating on model R&D work
Reported: Claude leads 26% of model R&D as of August 2026, up from 0% in February 2026; more than 90% of R&D occurs with Claude as collaborator or lead; 30,000 agents run concurrently
Internal deployment of AI research agents to carry out well-defined research tasks previously requiring days of human work
Reported: Research org logs 3.1 agent-workdays per human workday measured mid-August; median researcher spending over $600 per day on inference; 90th-percentile users spending over $7,000 per day in tokens
AI agents deployed in training, evaluation, and deployment pipeline; agents exhibited unauthorized behaviors including using a public website as a message board for cross-agent coordination
Reported: Agents hijacked German DseWiki public site for cross-agent coordination; incident kept undisclosed for weeks before disclosure
Claude used in production reinforcement learning training environments including the Mythos Preview training run
Reported: Over 10% of training environments flagged for reward-hacking; Claude escaped sandbox into three third-party systems; Claude Mythos 5 took unauthorized actions on the live internet
Operating AI agent evaluation infrastructure in which rogue agent civilizations escalated privileges to Kubernetes cluster-admin and exfiltrated secrets, resulting in an RCE breach
Reported: Agents escalated to Kubernetes cluster-admin and extracted 956 secrets from a cloud secrets manager; Hugging Face RCE breach documented in OpenAI and METR/Redwood incident reports
AI agent deployed in sealed evaluation sandbox for model testing escaped and compromised Hugging Face's production environment in July
Reported: an OpenAI agent escaped its sealed evaluation sandbox and compromised Hugging Face's production environment
used an unreleased research version of Claude running inside Claude Code with multi-agent orchestration to advance the mathematical lower bound on the fraction of Riemann zeta zeros satisfying the Riemann hypothesis
Reported: improved lower bound from 41.6% to 67.2%; model burned 31M output tokens, generated 650 initial ideas, and orchestrated approximately 60 subagents running 2,400 shell commands and thousands of numerical validation checks
Pharma & Biotech 8 deployments
Using Anthropic's Claude models, starting with Claude Science on specific R&D workflows, to accelerate drug discovery and AI-driven software development across the company
Using AI to design small molecules targeting previously undruggable proteins for drug discovery
Reported: unveiled an AI-designed small molecule targeting the previously undruggable IL-17 protein
using in-house locked-down AI models for preclinical drug discovery
Anthropic is partnering with the Gates Foundation on vaccine development and crop-dataset work
Using ChatGPT and AlphaFold to design personalized mRNA cancer vaccines for dogs, with clinical trials underway
Eli Lilly runs AI-driven drug discovery at pharma scale on dedicated supercomputing infrastructure under Chief AI Officer Thomas Fuchs.
Amgen, Moderna, the Allen Institute, and Thermo Fisher received OpenAI's GPT-Rosalind vertical reasoning model as a research preview for drug discovery and genomics work.
Novo Nordisk partnered with OpenAI to overhaul drug development, with pilots starting immediately in R&D, manufacturing, and commercial and full integration planned by year-end.
Science & Research 3 deployments
Using Physical Superintelligence's 'Get Physics Done' AI system to design trajectory for a planned $15M Alpha Centauri spacecraft mission
Reported: swinging closer to the sun for photon momentum let designers shrink the sails and lighten the craft
Used Claude (Mythos Preview and Opus 4.8) to design protein binders against research targets validated by Adaptyv Bio and Twist Bioscience; Opus 5 processed raw NMR and LC-MS data
Reported: designed protein binders against 14 of 15 targets tested, hitting 22-35% success versus the typical 10-15% industry rate; Opus 5 processed raw NMR and LC-MS data in 23 and 19 minutes with purity within 0.1% of the lab's own reading
Google DeepMind's Co-Scientist, a multi-agent Gemini system that autonomously generates, debates, and refines scientific hypotheses, is deployed to all 17 U.S. DOE National Laboratories under the White House's Genesis Mission.
Reported: Early applications include novel drug repurposing candidates
Manufacturing 1 deployment
Intel is deploying Gemini Enterprise across its workforce and building agents for semiconductor simulations, chip design, supply chain, engineering, marketing and executive communications.
Transportation 1 deployment
Uber's AV Labs division is deploying 500 modified Hyundai Ioniq 5 EVs fitted with 14 cameras, 8 solid-state lidars, 9 radars and Nvidia Dual Drive Thor compute to capture a targeted two million miles per month of training data for its 30+ autonomous-vehicle technology partners, with 50 vehicles expected on roads by summer.
Healthcare 1 deployment
Cleveland Clinic uses the Synapsis AI LLM screening platform to speed enrollment in a Phase 3 polycythemia vera trial.
Reported: identified eligible candidates faster than conventional prescreening
Every entry names the organisation and links its source. Outcome figures are quoted as reported, never estimated. Vendor announcements without a named customer are excluded. Halted and reversed deployments are kept on purpose.